184 related articles for article (PubMed ID: 27220594)
21. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
[TBL] [Abstract][Full Text] [Related]
22. HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
Lee KE; Choi SE; Xu H; Kang JH; Park DJ; Lee SS
Rheumatol Int; 2017 Dec; 37(12):2027-2034. PubMed ID: 28956118
[TBL] [Abstract][Full Text] [Related]
23. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
24. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis.
Patel S; Farragher T; Berry J; Bunn D; Silman A; Symmons D
Arthritis Rheum; 2007 Jul; 56(7):2143-9. PubMed ID: 17599737
[TBL] [Abstract][Full Text] [Related]
25. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
26. In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.
Balduzzi S; Scirè CA; Sakellariou G; Benaglio F; Bugatti S; Montecucco C; Caporali R
Clin Exp Rheumatol; 2017; 35(3):401-405. PubMed ID: 27974097
[TBL] [Abstract][Full Text] [Related]
27. Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.
Teitsma XM; Jacobs JWG; Welsing PMJ; de Jong PHP; Hazes JMW; Weel AEAM; Pethö-Schramm A; Borm MEA; van Laar JM; Lafeber FPJG; Bijlsma JWJ
Ann Rheum Dis; 2018 Sep; 77(9):1261-1267. PubMed ID: 29760159
[TBL] [Abstract][Full Text] [Related]
28. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
29. Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS.
Jayakumar K; Norton S; Dixey J; James D; Gough A; Williams P; Prouse P; Young A;
Rheumatology (Oxford); 2012 Jan; 51(1):169-75. PubMed ID: 22096011
[TBL] [Abstract][Full Text] [Related]
30. Has the severity of rheumatoid arthritis at presentation diminished over time?
Diffin JG; Lunt M; Marshall T; Chipping JR; Symmons DP; Verstappen SM
J Rheumatol; 2014 Aug; 41(8):1590-9. PubMed ID: 24986850
[TBL] [Abstract][Full Text] [Related]
31. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.
Nikiphorou E; Norton SJ; Carpenter L; Walsh DA; Creamer P; Dixey J; Young A; Kiely PDW;
Rheumatology (Oxford); 2020 Jun; 59(6):1272-1280. PubMed ID: 31580448
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
van der Woude D; Young A; Jayakumar K; Mertens BJ; Toes RE; van der Heijde D; Huizinga TW; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2262-71. PubMed ID: 19644846
[TBL] [Abstract][Full Text] [Related]
33. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.
Humphreys JH; Verheul MK; Barton A; MacGregor AJ; Lunt M; Toes RE; Symmons DP; Trouw LA; Verstappen SM
Ann Rheum Dis; 2016 Jun; 75(6):1139-44. PubMed ID: 26443608
[TBL] [Abstract][Full Text] [Related]
34. Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.
Wevers-de Boer KV; Heimans L; Visser K; Schouffoer AA; Molenaar ET; van Groenendael JH; Peeters AJ; Speyer I; Collée G; Huizinga TW; Allaart CF
Rheumatology (Oxford); 2015 Aug; 54(8):1380-4. PubMed ID: 25687553
[TBL] [Abstract][Full Text] [Related]
35. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
JAMA; 2019 Feb; 321(5):461-472. PubMed ID: 30721294
[TBL] [Abstract][Full Text] [Related]
36. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
37. The NOAR Damaged Joint Count (NOAR-DJC): a clinical measure for assessing articular damage in patients with early inflammatory polyarthritis including rheumatoid arthritis.
Bunn DK; Shepstone L; Galpin LM; Wiles NJ; Symmons DP
Rheumatology (Oxford); 2004 Dec; 43(12):1519-25. PubMed ID: 15316124
[TBL] [Abstract][Full Text] [Related]
38. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden.
Einarsson JT; Willim M; Ernestam S; Saxne T; Geborek P; Kapetanovic MC
Rheumatology (Oxford); 2019 Feb; 58(2):227-236. PubMed ID: 29538755
[TBL] [Abstract][Full Text] [Related]
40. Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).
Sugihara T; Ishizaki T; Hosoya T; Iga S; Yokoyama W; Hirano F; Miyasaka N; Harigai M
Rheumatology (Oxford); 2015 May; 54(5):798-807. PubMed ID: 25296748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
